| Dr Franco Rafael D'alessio, MD | |
|
5501 Hopkins Bayview Cir, Asthma & Allergy Ctr Room 4a-62, Baltimore, MD 21224-6821 | |
| (410) 550-1282 | |
| (410) 550-2612 |
| Full Name | Dr Franco Rafael D'alessio |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 24 Years |
| Location | 5501 Hopkins Bayview Cir, Baltimore, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174661425 | NPI | - | NPPES |
| 019963000 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | T0280 (Maryland) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | D68347 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Johns Hopkins Bayview Medical Center | Baltimore, MD | Hospital |
| Johns Hopkins Hospital, The | Baltimore, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Johns Hopkins University | 8921903147 | 2692 |
News Archive
A powerful Monash Biomedicine Discovery Institute (BDI) collaboration has revealed that a bacterial superbug can prevent stem cells in the gut from carrying out their vital role of regenerating the inner lining of the intestine.
Lack of time, knowledge and training in health promotion and lack of success with changing patient behavior were among the top barriers to including effective physical activity counseling in the primary care setting, according to research by The University of Texas School of Public Health, part of The University of Texas Health Science Center at Houston.
MicuRx Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development of antibiotics to treat drug-resistant bacteria, and Cumencor Pharmaceuticals, Inc. today announced that the companies have entered a collaboration with Pfizer to discover novel therapeutic agents to treat multi-drug resistant tuberculosis.
PharmAthene, Inc. announced today that new data from the Company's SparVax® next-generation anthrax vaccine program were presented in two separate oral presentations at the 2013 Bacillus – ACT international anthrax conference in Victoria, British Columbia, Canada.
The COVID-19 pandemic places a particular focus on older persons. Therefore, it comes as a surprise that the high-risk group of around 2.6 million care-dependent older persons in Germany who receive care at home, predominantly from their relatives, has been largely ignored by scientists, politicians, and society in general during this crisis.
› Verified 1 days ago
| Entity Name | Johns Hopkins University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922008549 PECOS PAC ID: 8921903147 Enrollment ID: O20031215000719 |
News Archive
A powerful Monash Biomedicine Discovery Institute (BDI) collaboration has revealed that a bacterial superbug can prevent stem cells in the gut from carrying out their vital role of regenerating the inner lining of the intestine.
Lack of time, knowledge and training in health promotion and lack of success with changing patient behavior were among the top barriers to including effective physical activity counseling in the primary care setting, according to research by The University of Texas School of Public Health, part of The University of Texas Health Science Center at Houston.
MicuRx Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development of antibiotics to treat drug-resistant bacteria, and Cumencor Pharmaceuticals, Inc. today announced that the companies have entered a collaboration with Pfizer to discover novel therapeutic agents to treat multi-drug resistant tuberculosis.
PharmAthene, Inc. announced today that new data from the Company's SparVax® next-generation anthrax vaccine program were presented in two separate oral presentations at the 2013 Bacillus – ACT international anthrax conference in Victoria, British Columbia, Canada.
The COVID-19 pandemic places a particular focus on older persons. Therefore, it comes as a surprise that the high-risk group of around 2.6 million care-dependent older persons in Germany who receive care at home, predominantly from their relatives, has been largely ignored by scientists, politicians, and society in general during this crisis.
› Verified 1 days ago
| Entity Name | Johns Hopkins University |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1902332133 PECOS PAC ID: 4981745098 Enrollment ID: O20170818000085 |
News Archive
A powerful Monash Biomedicine Discovery Institute (BDI) collaboration has revealed that a bacterial superbug can prevent stem cells in the gut from carrying out their vital role of regenerating the inner lining of the intestine.
Lack of time, knowledge and training in health promotion and lack of success with changing patient behavior were among the top barriers to including effective physical activity counseling in the primary care setting, according to research by The University of Texas School of Public Health, part of The University of Texas Health Science Center at Houston.
MicuRx Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development of antibiotics to treat drug-resistant bacteria, and Cumencor Pharmaceuticals, Inc. today announced that the companies have entered a collaboration with Pfizer to discover novel therapeutic agents to treat multi-drug resistant tuberculosis.
PharmAthene, Inc. announced today that new data from the Company's SparVax® next-generation anthrax vaccine program were presented in two separate oral presentations at the 2013 Bacillus – ACT international anthrax conference in Victoria, British Columbia, Canada.
The COVID-19 pandemic places a particular focus on older persons. Therefore, it comes as a surprise that the high-risk group of around 2.6 million care-dependent older persons in Germany who receive care at home, predominantly from their relatives, has been largely ignored by scientists, politicians, and society in general during this crisis.
› Verified 1 days ago
| Entity Name | Johns Hopkins University |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1689162034 PECOS PAC ID: 8921903147 Enrollment ID: O20210304001235 |
News Archive
A powerful Monash Biomedicine Discovery Institute (BDI) collaboration has revealed that a bacterial superbug can prevent stem cells in the gut from carrying out their vital role of regenerating the inner lining of the intestine.
Lack of time, knowledge and training in health promotion and lack of success with changing patient behavior were among the top barriers to including effective physical activity counseling in the primary care setting, according to research by The University of Texas School of Public Health, part of The University of Texas Health Science Center at Houston.
MicuRx Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development of antibiotics to treat drug-resistant bacteria, and Cumencor Pharmaceuticals, Inc. today announced that the companies have entered a collaboration with Pfizer to discover novel therapeutic agents to treat multi-drug resistant tuberculosis.
PharmAthene, Inc. announced today that new data from the Company's SparVax® next-generation anthrax vaccine program were presented in two separate oral presentations at the 2013 Bacillus – ACT international anthrax conference in Victoria, British Columbia, Canada.
The COVID-19 pandemic places a particular focus on older persons. Therefore, it comes as a surprise that the high-risk group of around 2.6 million care-dependent older persons in Germany who receive care at home, predominantly from their relatives, has been largely ignored by scientists, politicians, and society in general during this crisis.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Franco Rafael D'alessio, MD Po Box 64264, Baltimore, MD 21264-4264 Ph: (410) 550-5864 | Dr Franco Rafael D'alessio, MD 5501 Hopkins Bayview Cir, Asthma & Allergy Ctr Room 4a-62, Baltimore, MD 21224-6821 Ph: (410) 550-1282 |
News Archive
A powerful Monash Biomedicine Discovery Institute (BDI) collaboration has revealed that a bacterial superbug can prevent stem cells in the gut from carrying out their vital role of regenerating the inner lining of the intestine.
Lack of time, knowledge and training in health promotion and lack of success with changing patient behavior were among the top barriers to including effective physical activity counseling in the primary care setting, according to research by The University of Texas School of Public Health, part of The University of Texas Health Science Center at Houston.
MicuRx Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development of antibiotics to treat drug-resistant bacteria, and Cumencor Pharmaceuticals, Inc. today announced that the companies have entered a collaboration with Pfizer to discover novel therapeutic agents to treat multi-drug resistant tuberculosis.
PharmAthene, Inc. announced today that new data from the Company's SparVax® next-generation anthrax vaccine program were presented in two separate oral presentations at the 2013 Bacillus – ACT international anthrax conference in Victoria, British Columbia, Canada.
The COVID-19 pandemic places a particular focus on older persons. Therefore, it comes as a surprise that the high-risk group of around 2.6 million care-dependent older persons in Germany who receive care at home, predominantly from their relatives, has been largely ignored by scientists, politicians, and society in general during this crisis.
› Verified 1 days ago
Dr. Leonard Anang Sowah, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-706-4619 Fax: 410-706-2062 | |
Dr. Bhavandeep Singh Bajaj, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3345 Wilkens Avenue, Suite L10, Baltimore, MD 21229 Phone: 410-644-4444 Fax: 410-644-4484 | |
Dr. Yonas Sisay, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 822 Guilford Ave, #100, Baltimore, MD 21202 Phone: 410-385-9672 | |
Dr. Stephen John Witanowski, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 2700 Quarry Lake Dr, Suite 280, Baltimore, MD 21209 Phone: 410-469-5544 Fax: 410-585-2867 | |
Dr. Susrutha Kotwal, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4940 Eastern Ave, Mfl Bldg, West Tower, 6th Floor, Baltimore, MD 21224 Phone: 410-550-5018 | |
Dr. Mitesh G Trambadia, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 6701 N Charles St Ste 5218, Baltimore, MD 21204 Phone: 443-849-3786 | |
Ronak K Patel, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 201 E University Pkwy, Baltimore, MD 21218 Phone: 410-554-2000 |